PET studies have shown a slight increase of this receptor subtype in schizophrenia in striatum8, and in parallel striatal D2-R has in several studies been reported to be associated with measures of processing speed and executive function in healthy subjects12–14 as well as in drug-free patients with schizophrenia15. The gene discussed is DRD2; the disease is schizophrenia.